Phan Trieu Phu

TB Group - @OUCRU_Programme

[Enezator @Enezator]

What shapes a child’s future more: intelligence or education? 📚

[World Health Organization (WHO) Western Pacific @WHOWPRO]

Congratulations to #VietNam for eliminating trachoma as a public health problem! 👏

On behalf of WHO, @RD_WPRO presents a plaque and certificate in recognition of the achievement to 🇻🇳 #RCM75 country delegates led by Vice Minister of Health Assoc Prof Dr Nguyen Thi Lien Huong.

[Phan Trieu Phu @trieuphu10]

Had 3 productive days in Rio De Janeiro at the 7th Global Forum on TB Vaccine #7GFTBV, where scientists, stakeholders and affected communities from around the world gathered to share results and new ideas for advacing TB vaccine development. #EndTB

[Phan Trieu Phu @trieuphu10]

Support the demands of the global TB community for the development and rollout of new TB vaccines.

Join the call, sign the Community Declaration of the 7th @GlobForumTBVax! In Eng, Esp, Fra, Hin, Indon, Por, Rus!

📅 Deadline: Sun, 6 Oct 2024

✒️https://t.co/yI4ES8WQ1x

[Gwen Knight @gmknght]

This position is now open - do consider applying or get in touch if you are interested in #AMR & DR-TB. Partners with Indonesia, India, Brazil and South African mean that we'll be able to do some nice cross-country explorations of DR-TB drivers.

https://t.co/4w0gAN15ox

[Tropical Medicine Oxford @TropMedOxford]

Research Highlight from Thinh Ong Phuc @OUCRU_Programme

#HospitalAcquired infections and unvaccinated children due to chronic diseases: an investigation of the 2017–19 #measles outbreak in the northern region of Vietnam

https://t.co/jmlRXQoDMw
https://t.co/2gdJFMNK0u

[Graeme Meintjes @graemein]

A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of drug-resistant tuberculosis (DR-TB).
Includes new 6-month & group of 9-month regimens:

https://t.co/kG4ICC0n0o

[LSHTM TB Centre @LSHTM_TB]

Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies - The Lancet Respiratory Medicine https://t.co/HVbuUFynU2

[𝔻𝕣. 𝔸𝕙𝕞𝕖𝕕 𝕆𝕘𝕨𝕖𝕝𝕝 - DFAPH @laktarr001]

I encourage young people who are eligible and have a keen interest to apply and serve #globalhealth. #Youth, you are not just our future you are our present too!

@GlobalFund
@unfoundation
@beatmalaria
@ShotAtLife

https://t.co/KbRkoqgLAF

[Richard White @richardwhite321]

Fantastic news that new vaccines for #TB will be included in GAVI's future portfolio.

Huge credit to @MTufet , her team and @gavi !

Glad to support

@AllisonPortnoy @ra_clark18 Nick Menzies and all
@LSHTM @cmmid_lshtm @LSHTM_TB @LSHTM_Vaccines

https://t.co/MttsVstC5O

[Tereza Kasaeva @TerezaKasaeva]

#HappeningNow! Second High-Level Meeting of #TB Vaccine Accelerator Council. We are discussing
3 key acceleration tracks:
🟢Accelerate diversification of TB vaccine portfolio
🟢Accelerate identification of market solutions
🟢Accelerate rapid implementation&uptake of TB vaccines

[LSHTM TB Modelling Group @lshtm_tbmod]

📣 New article now in @FrontiersIn #Tuberculosis 📣

We held a #workshop to ask experts from countries with a high TB burden what #epi, #impact, #feasibility and #acceptability data they would need to decide whether to introduce new TB #vaccines 🌏🧮

https://t.co/X4Jdyqri3q

[The Lancet Reg Health-Southeast Asia @LancetRH_SEAsia]

New modeling shows the potential impact of #tuberculosis #vaccines M72/AS01E and BCG-revaccination in #India. M72/AS01E could avert 16% cases in Delhi and BCG-revaccination 8.8%

Read more
https://t.co/0RHdYaLUDW

[Anurag Bhargava @dranuragb]

The 3 HP regimen has better completion rates, lower hepatotoxicity than 6H/9H for LTBI, but systemic drug reactions can occur with low BMI as a risk.I argue for a relook at the uniform 900 mg INH dose in populations with undernutrition, need for pyridoxine, & to document AEs.

[Jess Potter @DrJessPotter]

Hoping lots of you can join us @UCLTB for another webinar in our TB medicines access series. We will be discussing access to rifapentine on 12th June 3pm GMT

You can find the zoom details and the link to our previous webinar below:

https://t.co/yairAVgtxO

[Phan Trieu Phu @trieuphu10]

https://t.co/41zi2xpkV2

[Treatment Action Group (TAG) @TAGTeam_Tweets]

SAVE THE DATE: TAG is hosting a webinar on May 15 on TB diagnostics research and development. Join us for info and discussion on new tools in the pipeline, and key considerations for implementation and advocacy.

Get details and register: https://t.co/THx42auNuj

[Nuffield Department of Medicine @NDMOxford]

A new study by @OxfordBRC, @JennerInstitute, @ImmunologyUoB, and @Respiratorymedi has established an innovative way to test #tuberculosis vaccines using controlled aerosol lung infections. This could help develop better #TB vaccines 💉🦠🫁

Read more 👉 https://t.co/H1XcE4vC8b

[Anita S @mitokondrion]

New webinar on implementing targeted next-gen sequencing #tNGS for DR-TB detection 17 Apr 12.00 (GMT+2) @FINDdx @StopTB @UNITAID @USAID sign up now! https://t.co/6hXmVaie19 #SeqnTreat @paimadhu @WHO @TheUnion_TBLH @msf_tb @CDC_TB @TAGTeam_Tweets

[TBnet @TBnet_EU]

The recording for the TBnet webinar "Targeted next generation sequencing for detection of drug-resistant tuberculosis" is now available!

https://t.co/4x1EJSHYXk